PL3013363T3 - Szczepionka przeciwko dyzenterii świń - Google Patents

Szczepionka przeciwko dyzenterii świń

Info

Publication number
PL3013363T3
PL3013363T3 PL14734127T PL14734127T PL3013363T3 PL 3013363 T3 PL3013363 T3 PL 3013363T3 PL 14734127 T PL14734127 T PL 14734127T PL 14734127 T PL14734127 T PL 14734127T PL 3013363 T3 PL3013363 T3 PL 3013363T3
Authority
PL
Poland
Prior art keywords
swine dysentery
dysentery vaccine
vaccine
swine
dysentery
Prior art date
Application number
PL14734127T
Other languages
English (en)
Inventor
Pedro Miguel Rubio Nistal
Ana María Carvajal Ureña
Marta GARCÍA DÍEZ
Original Assignee
Aquilón Cyl S.L.
Universidad De León
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquilón Cyl S.L., Universidad De León filed Critical Aquilón Cyl S.L.
Publication of PL3013363T3 publication Critical patent/PL3013363T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/116Polyvalent bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL14734127T 2013-06-28 2014-06-27 Szczepionka przeciwko dyzenterii świń PL3013363T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13382255 2013-06-28
EP14734127.5A EP3013363B9 (en) 2013-06-28 2014-06-27 Swine dysentery vaccine
PCT/EP2014/063695 WO2014207202A1 (en) 2013-06-28 2014-06-27 Swine dysentery vaccine

Publications (1)

Publication Number Publication Date
PL3013363T3 true PL3013363T3 (pl) 2021-04-06

Family

ID=48703385

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14734127T PL3013363T3 (pl) 2013-06-28 2014-06-27 Szczepionka przeciwko dyzenterii świń

Country Status (10)

Country Link
US (1) US9855322B2 (pl)
EP (1) EP3013363B9 (pl)
CN (1) CN105611941B (pl)
AU (1) AU2014300951B2 (pl)
BR (1) BR112015032468B1 (pl)
DK (1) DK3013363T3 (pl)
ES (1) ES2828873T3 (pl)
PL (1) PL3013363T3 (pl)
RU (1) RU2692647C2 (pl)
WO (1) WO2014207202A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10188715B2 (en) 2013-06-28 2019-01-29 Aquilon Cyl Sociedad Limitada Swine dysentery vaccine
WO2019081583A1 (en) 2017-10-24 2019-05-02 Aquilon Cyl S.L. VACCINE AGAINST SINGLE STEM DYSENTERY
CA3203697A1 (en) 2020-12-29 2022-07-07 Jesus Maria Osorio Arguello Immunogenic and vaccine compositions against swine dysentery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100272A (en) 1977-05-31 1978-07-11 Iowa State University Research Foundation, Inc. Method of increasing the resistance of swine to swine dysentery infection
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5236708A (en) * 1989-11-03 1993-08-17 Iowa State University Research Foundation, Inc. Reduced-protein subunit vaccine for swine dysentery
FR2707168B1 (fr) * 1993-07-08 1995-08-18 Rhone Merieux Vaccin contre la dysenterie hémorragique du porc et ensemble de vaccination y relatif.
US7851212B2 (en) * 2000-05-10 2010-12-14 Sanofi Pasteur Limited Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
RU2440369C2 (ru) * 2007-08-03 2012-01-20 Бёрингер Ингельхайм Ветмедика Гмбх ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ
MX2011005135A (es) * 2008-11-14 2011-10-24 Boehringer Ingelheim Vetmed Cepas de vacuna de brachyspira hyodysenteriae.
US8057805B1 (en) * 2010-07-29 2011-11-15 Schweitzer Biotech Company Ltd. Edwardsiella ictaluri E-ict-VL33 strain, vaccines thereof, and a method for protecting fishes using said vaccines

Also Published As

Publication number Publication date
CN105611941B (zh) 2019-12-10
US20160184418A1 (en) 2016-06-30
EP3013363B9 (en) 2021-04-14
BR112015032468A2 (pt) 2018-01-23
BR112015032468B1 (pt) 2023-03-07
CN105611941A (zh) 2016-05-25
DK3013363T3 (da) 2020-10-19
EP3013363A1 (en) 2016-05-04
EP3013363B1 (en) 2020-07-15
US9855322B2 (en) 2018-01-02
RU2692647C2 (ru) 2019-06-25
WO2014207202A1 (en) 2014-12-31
ES2828873T3 (es) 2021-05-27
RU2016102767A (ru) 2017-08-03
AU2014300951A1 (en) 2016-01-21
AU2014300951B2 (en) 2019-05-16

Similar Documents

Publication Publication Date Title
IL276210A (en) MERS-COV vaccine
IL279395A (en) A vaccine
IL244816A0 (en) Protein-polymer-drug conjugates
IL245009A0 (en) Attach a drug from a protein and a polymer
GB201319791D0 (en) Formulations
SG11201605260VA (en) Var2csa-drug conjugates
ZA201508642B (en) Malaria vaccine
GB201315946D0 (en) Oncology vaccine
GB201318084D0 (en) Malaria vaccination
GB201321384D0 (en) Molecular adjuvant
PT2968493T (pt) Vacinas melhoradas contra o vírus da varíola
GB201301085D0 (en) Glycoconjugate Vaccine
GB201319792D0 (en) Formulations
IL245420A0 (en) New formulations
PL2944730T3 (pl) Miska ustępowa sedesu
GB201320432D0 (en) Novel formulation
PL2958935T3 (pl) Szczepionka
GB201322948D0 (en) Improved formulation
GB201317718D0 (en) Novel formulation
PL3013363T3 (pl) Szczepionka przeciwko dyzenterii świń
GB2547494B (en) Monovalent H5 vaccine
PL2991675T3 (pl) Szczepionka Campylobacter
GB201320646D0 (en) Vaccine
GB201315556D0 (en) Vaccine
GB201320421D0 (en) Conjugated vaccine